Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
General Rheumatology
•
COVID-19 virus
Are you recommending a 4th dose of mRNA SARS-COV-2 vaccine for patients on DMARDs and biologics?
Related Questions
What isolation policies are Rheumatology offices employing for both staff and patients diagnosed with COVID-19 given the new CDC guidelines?
What treatment options do you recommend in a patient with idiopathic granulomatous mastitis that has not improved on steroids and methotrexate?
When is it safe to resume DMARDs in a patient who was diagnosed with active TB and started on treatment?
How do you approach endocarditis prophylaxis for patients with rheumatic diseases undergoing invasive dental surgery and no history of joint replacement?
How do you approach treating a patient with RA and cirrhosis who did not respond to csDMARDs?
How do you approach pre-conception counseling in males who are on medications for which there is limited or no data such as Jak inhibitors, apremilast, or belimumab?
Do you have concerns with the use of oral contraceptives in patients on JAK inhibitors given the black box warning for thromboembolic events?
Would you feel comfortable adding benlysta to patient already taking both mycophenolate and tacrolimus (and hydroxychloroquine) who still has some evidence of active lupus nephritis?
What is your approach to patients with severe sicca symptoms and history of B Cell lymphoma?
For how long do you recommend treatment for latent tuberculosis prior to initiation of anti-TNF therapy?
